The 'Delta' variant of coronavirus has evolved to form a 'Delta Plus' or AY.1 variant. It is characterized by the K417N mutation in the spike protein of the SARS-CoV2 virus that causes the COVID-19 disease. Scientists say there is "no cause for concern yet" but could it have immune escape tendencies. Will monoclonal antibody treatment work? We discuss.
